Spirit CML

Spirit CML

Welcome to the SPIRIT 2 website

STI571 Prospective International RandomIsed Trial 2
A phase III, prospective randomised comparison of
-imatinib (STI571, Glivec/Gleevec) 400mg daily versus

  • dasatinib (Sprycel) 100mg daily
    in patients with newly-diagnosed chronic phase chronic myeloid leukaemia

Closed to recruitment: March 2013
Last patient last visit : March 2018

Slot online

Spirit CML

Spirit CML

Pages

  • About Spirit Home 2
  • Spirit Home 2
  • Welcome to the SPIRIT 2 website
Copyright © 2022 Spirit CML